Caberos (Cabergoline) 0.125mg Driada Medical – 20 Tablets
Caberos (Cabergoline) 0.125mg Driada Medical – 20 Tablets
For high-performance athletes and bodybuilders executing heavy anabolic cycles, maintaining hormonal equilibrium is paramount. Caberos by Driada Medical is an elite-grade oral dopamine receptor agonist formulated with 0.125 mg of pharmaceutical Cabergoline per tablet. Priced competitively at €44.00 per 20-tablet pack, Caberos stands as the ultimate defense against elevated prolactin levels induced by 19-nor anabolic steroids such as Trenbolone and Nandrolone Decanoate. Available exclusively at Steroids EU, every batch of Driada products undergoes rigorous Janoshik lab testing to guarantee top-tier purity, backed by our 100% customs-free shipping across the European Union.
Benefits & Pharmacological Action in Bodybuilding
Cabergoline functions as a direct agonist on dopamine D2 receptors located within the anterior pituitary gland. By stimulating these receptors, Caberos suppresses the secretion of prolactin at its cellular source. Controlling prolactin provides critical advantages for athletes engaging in enhanced cycles:
- Prevention of Prolactin-Induced Gynecomastia: While aromatase inhibitors tackle estrogen, high prolactin levels can trigger lactation and severe glandular tissue growth even when estrogen is controlled. Incorporating Cabergoline completely prevents hyperprolactinemia-related gynecomastia.
- Elimination of Performance Dysfunction: High prolactin suppressed luteinizing hormone (LH) and drastically impairs sexual health. Caberos eliminates "Tren-dick" and "Deca-dick" by restoring normal erectile function and improving overall stamina during intensive training cycles.
- Drastic Reduction of the Refractory Period: By activating central dopamine receptors and suppressing prolactin, Cabergoline significantly shortens recovery time between physical encounters, enhancing sexual performance and biological drive.
- Enhanced Dopaminergic Drive and Mood Stability: Dopamine directly influences drive, motivation, and mental focus. Maintaining baseline prolactin levels elevates psychological well-being during aggressive cutting or bulking phases.
- Water Retention Mitigation: Prolactin spikes often contribute to soft, puffy fluid accumulation. Caberos helps maintain a hard, vascular, and defined physical appearance.
Dosage & Cycle Administration Protocol
Because Cabergoline is exceptionally potent with an extended active half-life of 63 to 68 hours, micro-dosing is the safest and most efficient protocol. Driada Medical’s 0.125 mg formulation allows precise dosing control without over-suppressing baseline prolactin levels.
Standard On-Cycle Prolactin Management
For athletes utilizing moderate dosages of Nandrolone, Trenbolone, or related progestogenic compounds:
- Dosage: 0.125 mg (1 tablet) taken every 3 to 4 days (twice per week).
- Timing: Consume with a meal, preferably before sleep, to minimize mild dopaminergic side effects such as transient dizziness.
- Duration: Maintain dosing throughout the active duration of 19-nor compound usage. Discontinue once the injectable esters have cleared the body.
Advanced Heavy Compound Protocol
For athletes running elevated doses of harsh compounds or individuals prone to rapid prolactin spikes (verified by blood diagnostics):
- Dosage: 0.25 mg (2 tablets) taken every 3 to 4 days.
- Monitoring: Always conduct bloodwork before increasing dosages. Prolactin should be reduced into the mid-normal range, not completely crushed, as low prolactin levels can cause fatigue and joint discomfort.
Post-Cycle Therapy Integration
During post-cycle therapy (PCT), elevated prolactin can hinder endogenous testosterone restart. Using Caberos at 0.125 mg once per week alongside selective estrogen receptor modulators (SERMs) such as Clomid and Nolvadex accelerates pituitary recovery and natural HPTA axis reactivation.
Side Effects & Risk Mitigation Strategy
Caberos is well-tolerated when administered within recommended conservative parameters. However, unmonitored overuse can lead to specific side effects:
- Hypotension (Low Blood Pressure): Dopamine agonists induce mild vasodilation. Monitor blood pressure levels regularly.
- Gastrointestinal Distress: Mild nausea or abdominal discomfort can occur; administering tablets alongside evening meals mitigates this response.
- Central Nervous System Effects: Temporary lightheadedness or headache upon standing. Restrict alcohol consumption while taking Cabergoline.
To optimize safety, pair Caberos with appropriate estrogen management tools such as Arimidex or Aromasin depending on blood chemistry, and consider secondary supporting agents such as ED solutions if multi-factorial performance recovery is required.
Why Buy Caberos Driada from Steroids EU?
Steroids EU is the primary European distributor for authentic pharmaceutical-grade performance enhancers. When ordering Caberos (Cabergoline) 0.125 mg from our shop, you benefit from:
- Janoshik Analytical Verification: Every Driada batch is independently lab-tested for exact dosage precision and total chemical purity.
- 100% Customs-Free UK & EU Shipping: Orders are dispatched domestically within EU borders, eliminating customs inspections or import delays.
- Discreet Packaging: Products are packaged securely and discreetly to preserve your privacy.
Frequently Asked Questions
Why is Cabergoline essential during Trenbolone or Deca Durabolin cycles?
19-nor steroid derivatives bind directly to progesterone receptors, triggering excess prolactin secretion. Elevated prolactin causes water retention, mood swings, loss of libido, and prolactin-induced gynecomastia. Caberos suppresses pituitary prolactin production to keep levels within normal biological ranges.
What is the active half-life of Caberos and how often should I take it?
Caberos (Cabergoline) features a long active half-life of approximately 63 to 68 hours. Due to this sustained activity, daily dosing is unnecessary. Most bodybuilders take 0.125 mg to 0.25 mg once every 3 to 4 days (twice per week).
How quickly does Caberos lower prolactin levels?
Cabergoline begins lowering serum prolactin within 3 hours of administration, reaching peak suppression within 48 to 72 hours. Sustained control is achieved within 1 to 2 weeks of consistent dosing according to cycle protocols.
this product yet